DOAN THUY NGUYEN: Open Payments
NPI 1710566047 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $501
Food & beverage: $416Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $152 |
| REVANCE THERAPEUTICS, INC. | 2 | $97 |
| Janssen Biotech, Inc. | 1 | $85 |
| Incyte Corporation | 3 | $62 |
| ABBVIE INC. | 2 | $48 |
| UCB, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $26 |
Products named: NEMLUVIO, DAXXIFY, TREMFYA, OPZELURA, RINVOQ, Bimzelx, TALTZ, AKLIEF.
Industry payments across CA — which companies pay providers there.
